Bone mineral density assessed by dual-energy X-ray absorptiometry in patients with viral or alcoholic compensated cirrhosis. A prospective study - 06/12/11
, J. Reboul-Marty c , G. Chalès d , Y. Lalatonne e , V. Bourcier a , V. Grando a , N. Barget a , M. Beaugrand a , J.-C. Trinchet a , N. Ganne-Carrié a, ⁎ 
Corresponding author. Tel.: +33 1 48 02 62 80; fax: +33 1 48 02 62 02.Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
| pagine | 7 |
| Iconografia | 0 |
| Video | 0 |
| Altro | 0 |
Summary |
Background/aim |
Cirrhosis is considered as a risk factor for osteoporosis whose prevalence is poorly known. The aim was to assess prospectively bone mineral density (BMD) in patients with alcoholic or viral compensated cirrhosis.
Methods |
From 2006 to 2008, patients with viral or alcoholic compensated cirrhosis had BMD assessment by dual-energy X-ray absorptiometry. The prevalence of osteopenia (−2.5SD<T-score<−1SD) and osteoporosis (T-score≤−2.5SD), and the influence of age, gender and aetiology of cirrhosis were assessed using univariate and multiple regression analysis.
Results |
One hundred and nine patients were studied (72 men, 55.3±11.4 years and 37 women, 65.2±11.0); with HBV (n=35), HCV (n=43), or alcoholic cirrhosis (n=31). At the lumbar spine, 25 patients had osteopenia and 12 had osteoporosis. At the femoral site, 23 had osteopenia and 4 had osteoporosis. Female gender had an independent decreased effect on the total BMD.
Conclusions |
The prevalence of osteoporosis was up to 11% at the lumbar spine, greater in women independently of age, without significant difference according to the aetiology of cirrhosis.
Il testo completo di questo articolo è disponibile in PDF.Abbreviations : BMD, DXA, WHO, HCV, HBV, SD
Mappa
Vol 35 - N° 11
P. 731-737 - Novembre 2011 Ritorno al numero
Articolo precedente
- FibroTest® and Fibroscan® performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate
- Thierry Poynard, Victor de Ledinghen, Jean-Pierre Zarski, Carol Stanciu, Mona Munteanu, Julien Vergniol, Julie France, Anca Trifan, Joseph Moussalli, Pascal Lebray, Dominique Thabut, Vlad Ratziu
- Therapeutic strategies for severe alcoholic hepatitis
- Yoshinori Horie, Yoshiyuki Yamagishi, Hirotoshi Ebinuma, Toshifumi Hibi
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?